Risk factors of renal insufficiency in patients with chronic obstructive pulmonary disease; A systematic review and meta-analysis

Author:

QIAN CAI HUA1,MAO WEI2,LU CHEN1

Affiliation:

1. Huzhou Central Hospital & Affiliated Cent. Hosp, HuZhou University

2. Huzhou Traditional Chinese Medicine Hospital, Zhejiang Chinese Medical University

Abstract

Abstract Background Chronic obstructive pulmonary disease (COPD) is a progressive, systematic inflammatory disorder. Chronic kidney disease (CKD) is frequently associated with COPD. A number of risk factors of CKD have been investigated among patients living with COPD. Conversely, the findings of the previous studies are contradictory and inconsistent. The present systematic review and meta-analysis revealed the risk of chronic renal insufficiency among patients living with COPD and patients-related and management-related risk factors. Methods Literature searching of twelve databases was performed on 14 July 2023. All clinical studies comparing the patients-related, COPD-related, and management-related variables among patients with COPD who developed chronic renal insufficiency and control groups were eligible. Studies reported the potential predictors of chronic renal insufficiency among patients with COPD were included. Results This meta-analysis included nine studies, encompassing 64289 patients with COPD. Of them, 10217 patients developed CKD, while 54072 had no-CKD. The risk of CKD after COPD was 22.5% (event rate 0.225, 95%CI; 17.2, 0.289; p < 0.001). Elderly patients (MD;5.50 years ,95%CI; 2.99, 8.02; p < 0.001), hypertensive patients (RR; 1.47, 95%CI; 1.16, 1.85; P = 0.001), diabetic patients (RR; 2.27, 95%CI; 1.52 to 3.38; P < 0.001), and patients with peripheral vascular disease (RR; 1.52, 95%CI; 1.45, 1.6; P < 0.001) were at higher risk of CKD. Conclusions The present meta-analysis pointed out the considerable risk of CKD among patients with COPD. Elderly patients with hypertension, diabetes mellitus, stroke, or peripheral vascular diseases were at higher risk of CKD.

Publisher

Research Square Platform LLC

Reference35 articles.

1. Organization WH. Chronic obstructive pulmonary disease (COPD) World Health Organization. Geneva, Switzerland.; 2022.

2. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Soriano JB;The Lancet Respir Med,2020

3. Comorbidities of COPD;Cavaillès A;Eur Respir Rev,2013

4. Economic burden of COPD in a Swedish cohort: the ARCTIC study;Lisspers K;Int J of chronic obstructive pulm Dis

5. Excess economic burden of comorbidities in COPD: a 15-year population-based study;Chen W;Eur Respir J,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3